Literature DB >> 25875603

Cutaneous manifestations in antiphospholipid syndrome.

S Caporuscio1, M L Sorgi2, S Nisticò3, G Pranteda4, U Bottoni5, I Carboni6, E Del Duca5, G Pranteda4.   

Abstract

Antiphospholipid syndrome (APS) is a hypercoagulable state that leads to thrombosis and recurrent pregnancy loss related to the presence of antiphospholipid antibodies (LAC, anticardiolipin, antiA2-glycoprotein). Among cutaneous manifestations, livedo reticularis is the most frequent form of APS. In the literature, there are rare cases associated with diffuse skin necrosis (widespread skin necrosis) and intravascular thrombosis in the small vessels of the dermis. We describe the case of a 44-year-old man with positive anticardiolipin antibodies and protein S deficiency that developed scattered, bullous skin lesions, haemorrhagic in appearance with signs of necrosis as first clinical manifestation of antiphospholipid syndrome.
© The Author(s) 2015.

Entities:  

Keywords:  antiphosholipid syndrome; intravascular thrombosis; necrosis

Mesh:

Substances:

Year:  2015        PMID: 25875603     DOI: 10.1177/0394632015582344

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  3 in total

Review 1.  The Cutaneous Spectrum of Lupus Erythematosus.

Authors:  Simone Ribero; Savino Sciascia; Luca Borradori; Dan Lipsker
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  Digital ulcers as presenting symptom of secondary antiphospholipid syndrome.

Authors:  Karen Cravero; Austin J Maddy; Kiran Motaparthi
Journal:  JAAD Case Rep       Date:  2022-08-27

3.  Purpura fulminans-like lesions in antiphospholipid syndrome with endothelial C3 deposition.

Authors:  Jorge Magdaleno-Tapial; Cristian Valenzuela-Oñate; Javier Pitarch-Fabregat; María Marín-Jiménez; Clara Molina Almela; Johana Isidora Gutiérrez-Salcedo; Javier Calvo-Catalá; José Luis Sánchez-Carazo; V Alegre-de Miquel
Journal:  JAAD Case Rep       Date:  2018-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.